# US 2026/0076996 A1 · Composition for treating spinal cord injury, comprising stem cells treated with novel compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0076996 A1
- Document ID: US20260076996A1
- Status: Published application
- Kind: A1
- Application number: 19/399,582
- Filed: 2025-11-24
- Published: 2026-03-19
- Earliest claimed: 2025-11-24
- Assignees: Yj Cerapeutics Inc.
- Applicants: Yj Cerapeutics Inc.
- Inventors: Tae Young YUNE; Hea Young PARK; Jee Youn LEE; Sang Ryong JEON; Bong Gun JU
- Web page: https://patentgrep.com/patent/US20260076996A1

## CPC

- A61K 35/30: Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A61K 31/423: condensed with carbocyclic rings
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 5/0623: {Stem cells}
- C12N 2501/999: Small molecules not provided for elsewhere
- C12N 2506/1346: from mesenchymal stem cells
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a composition for treating a spinal cord injury and provides a composition for treating a spinal cord injury comprising, as an active ingredient, stem cells treated with a particular compound and then cultured.

## Claims

### Claim 1

A compound of Formula I below

### Claim 2 (depends on 1)

A method for producing stem cells, the method comprising steps of:
(a) treating the stem cells with the compound of claim 1; and
(b) culturing the stem cells treated with the compound for 96 hours to 144 hours.